Search
forResearch 10 of 587
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata and Alopecia Areata Incognita
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- 448 Combined therapeutic approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo
- Surgical Approaches for Repigmenting Vitiligo 2.0
- Anais do II Congresso Nacional Acadêmico de Dermatologia
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →